According to @StockMKTNewz, citing WSJ, Hims & Hers (HIMS) plans to offer treatments for menopause and perimenopause, indicating an expansion of its treatment lineup, source: @StockMKTNewz. The post provides no launch date, pricing, or product specifics, limiting immediate revenue and margin modeling for traders, source: @StockMKTNewz. Key near-term watchpoints are official company confirmation, product detail disclosures, and any regulatory or launch timeline updates to assess scope and sales potential, since the update is headline-only, source: @StockMKTNewz. The update contains no mention of crypto or blockchain integrations, indicating no direct crypto market impact from this headline alone, source: @StockMKTNewz.